Intervention Name

An Intervention Name is a generic name that used to refer to an experimental treatment or intervention being studied in an ongoing clinical trial.

• Example(s):
  • Erenumab (NCT04465357,
  • Infliximab (NCT04425538),
  • Olfactory Device (NCT04431908),
  • …
• Counter-Example(s):
  • NCT Number,
  • Board Approval Number.
• See: Expanded Access Clinical Trial, Clinical Trial Sponsor, Data Monitoring Committee, Investigational New Drug Application (IND), Human Subject, FDA Regulated Intervention, ClinicalTrials.gov, Clinical Trial Eligibility Criterion.

---

---

References

2022a

• (Wikipedia) ⇒ https://en.wikipedia.org/wiki/Glossary_of_clinical_research#I Retrieved:2022-3-20.
  • Intervention name
    • The generic name of the precise intervention being studied. (NLM)

2022b

• (ClinicalTrial.gov, 2022) ⇒ https://prsinfo.clinicaltrials.gov/definitions.html Retrieved:2022-3-20.
  • QUOTE: Intervention Name(s)
    • Definition: A brief descriptive name used to refer to the intervention(s) studied in each arm of the clinical study. A non-proprietary name of the intervention must be used, if available. If a non-proprietary name is not available, a brief descriptive name or identifier must be used.

---

.